Proposed score for survival of patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Proposed score for survival of patients with myelodysplastic syndromes

Published:2013-09 Issue: Volume: Page:n/a-n/a
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Sperr Wolfgang R.¹,Kundi Michael²,Wimazal Friedrich³,Nösslinger Thomas⁴,Schönmetzler-Makrai Anabel⁴,Stauder Reinhard⁵,Krieger Otto⁶,Neukirchen Judith⁷,Germing Ulrich⁷,Pfeilstöcker Michael,Valent Peter

Affiliation:

1. Division of Hematology and Hemostaseology, Department of Internal Medicine I; Medical University of Vienna; Vienna; Austria

2. Institute of Environmental Health; Medical University of Vienna; Vienna; Austria

3. Department of Obstetrics and Gynecology; Medical University of Vienna; Vienna; Austria

4. 3rd Medical Department for Hematology and Oncology; Hanusch Hospital; Vienna; Austria

5. Department of Internal Medicine V (Haematology and Oncology); Medical University of Innsbruck; Innsbruck; Austria

6. Department of Internal Medicine I; Hospital of the Elisabethinen Linz; Linz; Austria

7. Department of Hematology, Oncology and Clinical Immunology; Heinrich Heine University; Düsseldorf; Germany

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/eci.12149/fullpdf

Reference40 articles.

1. Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry;Neukirchen;Leuk Res,2011

2. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference;Valent;Leuk Res,2007

3. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes;Germing;Ann Hematol,2008

4. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

5. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia;Bennett;Br J Haematol,1994

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidities and frailty predict outcome of patients with myelodysplastic syndromes. Should we integrate them in novel prognostic scoring systems?;Journal of Geriatric Oncology;2021-09

2. Predicting outcome in higher-risk myelodysplastic syndrome patients treated with azacitidine;Epigenomics;2021-07

3. Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes;Therapeutic Advances in Hematology;2020-01

4. Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform;Expert Review of Hematology;2018-01-02

5. Multidisciplinary evaluation at baseline and during treatment improves the rate of compliance and efficacy of deferasirox in elderly myelodysplastic patients;International Journal of Clinical Oncology;2016-10-22